Beam Therapeutics · 1 month ago
Medical Science Liaison – Mid-Atlantic Region
DC/Baltimore/Richmond
Full-time
Onsite
Senior Level, Lead/Staff
$180K/yr - $220K/yr
10+ years expBeam Therapeutics is a biotechnology company focused on precision genetic medicines. The Medical Science Liaison will be responsible for executing territory strategy, engaging with key opinion leaders, and driving pre-commercial launch readiness for therapies in sickle cell disease and other genetic disorders.
BiotechnologyGeneticsMedicalTherapeutics
Responsibilities
Develop and execute territory strategy: map treatment centers, referral networks, transplant/infusion sites, cell-collection capabilities, payers, and advocacy groups; prioritize accounts and set measurable objectives
Support treatment center onboarding: coordinate scientific and operational readiness aligned with SOPs, compliance, and patient journey requirements; partner with internal teams for qualification and activation
Build trusted relationships with KOLs and HCPs: deliver fair-balanced, evidence-based education on rare diseases, cell and gene therapy science, and Beam’s platform; foster advocacy and awareness
Educate stakeholders on disease state, therapeutic landscape, and company platform to drive awareness and credibility in the rare disease and CGT space
Generate high-quality insights from field interactions: synthesize trends and communicate actionable recommendations to Medical Affairs leadership and cross-functional partners
Collaborate on pre-launch planning: align with Medical Strategy, Publications, Medical Information, Value & Evidence, and Medical Operations to ensure scientific messaging, data dissemination, and field tools are ready for first commercial launch
Support clinical research activities: identify potential sites, assist with feasibility assessments, and promote best practices for enrollment and retention while maintaining medical/scientific independence
Partner cross-functionally with Commercial, Market Access, and Clinical teams while preserving medical independence; coordinate account plans to ensure seamless patient access and avoid duplication
Represent the company at congresses and external scientific meetings: plan and execute presence, engage in meaningful scientific exchanges, and follow up to strengthen visibility and credibility
Provide education and resources to treatment centers on operational readiness for advanced therapies, including apheresis and cell-handling processes
Serve as a trusted resource for compliance and ethical standards: ensure all interactions and materials meet company policies, regulatory requirements, and industry codes
Maintain operational excellence: document activities and insights in CRM, monitor KPIs, and continuously improve processes, content, and tools
Prepare and deliver training for internal teams and external stakeholders on rare disease management and CGT fundamentals to support launch readiness
Act as a scientific ambassador for the company: articulate the value of the platform and pipeline to diverse audiences including clinicians, researchers, and advocacy groups
Monitor evolving evidence and competitive landscape in rare disease and CGT; share updates internally to inform strategy and decision-making
Qualification
Required
Advanced scientific degree (PharmD, PhD, MD, or equivalent)
~10+ years industry experience in Medical Affairs with significant Field Medical tenure
Rare disease expertise required
Proven territory management and account planning capability across complex ecosystems (academic centers, community networks, payers, advocacy)
Independent, proactive operator with strong ownership
Cross‑functional collaboration with Clinical, Regulatory, Commercial, Medical Operations, and Publications while maintaining medical/scientific integrity
Outstanding communication skills; ability to translate complex science into clear, credible narratives
Analytical strength for insight collection, synthesis, and actionable recommendations
Travel up to ~60% across assigned territory
Preferred
Hematology strongly preferred with emphasis on SCD
Small biotech experience preferred; demonstrated impact in resource‑constrained settings
Launch experience (pre‑approval to post‑launch), ideally in CGT or complex specialty (buy‑and‑bill) environments
Company
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.19B2025-03-10Post Ipo Equity· $500M
2021-01-19Post Ipo Equity· $260M
2020-02-11Post Ipo Equity· $207M
Leadership Team
John Evans
CEO
Christine Bellon
Chief Legal Officer
Recent News
2026-01-13
thefly.com
2026-01-13
Company data provided by crunchbase